APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalational Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalational Anesthesia Drugs Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchInhalational Anesthesia Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalational Anesthesia Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Inhalational Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalational Anesthesia Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalational Anesthesia Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Inhalational Anesthesia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalational Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalational Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalational Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalational Anesthesia Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalational Anesthesia Drugs market include Halocarbon Products, Piramal Enterprises, AbbVie, Baxter, Fresenius Kabi and Jiangsu Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalational Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalational Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalational Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalational Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalational Anesthesia Drugs Segment by Company

Halocarbon Products

Piramal Enterprises

AbbVie

Baxter

Fresenius Kabi

Jiangsu Hengrui Medicine

Inhalational Anesthesia Drugs Segment by Type

Isoflurane

Sevoflurane

Desflurane

Enflurane

Inhalational Anesthesia Drugs Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Inhalational Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhalational Anesthesia Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalational Anesthesia Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalational Anesthesia Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalational Anesthesia Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalational Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalational Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalational Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalational Anesthesia Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalational Anesthesia Drugs industry.

Chapter 3: Detailed analysis of Inhalational Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalational Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalational Anesthesia Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalational Anesthesia Drugs Industry Trends Table 2. Inhalational Anesthesia Drugs Industry Drivers Table 3. Inhalational Anesthesia Drugs Industry Opportunities and Challenges Table 4. Inhalational Anesthesia Drugs Industry Restraints Table 5. Global Inhalational Anesthesia Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalational Anesthesia Drugs Revenue Share by Company (2021-2026) Table 7. Global Inhalational Anesthesia Drugs Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Inhalational Anesthesia Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Inhalational Anesthesia Drugs Average Price (US$/ton) of Company (2021-2026) Table 10. Global Inhalational Anesthesia Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalational Anesthesia Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Inhalational Anesthesia Drugs Company, Product Type & Application Table 13. Global Inhalational Anesthesia Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalational Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Isoflurane Table 18. Significant Companies of Sevoflurane Table 19. Significant Companies of Desflurane Table 20. Significant Companies of Enflurane Table 21. Global Inhalational Anesthesia Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 22. Global Inhalational Anesthesia Drugs Sales Volume by Type (2021-2026) & (k tons) Table 23. Global Inhalational Anesthesia Drugs Sales Volume by Type (2027-2032) & (k tons) Table 24. Global Inhalational Anesthesia Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Inhalational Anesthesia Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Inhalational Anesthesia Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Inhalational Anesthesia Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Inhalational Anesthesia Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Inhalational Anesthesia Drugs Sales Value Share by Type (2021-2026) Table 30. Global Inhalational Anesthesia Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Ambulatory Surgical Centers Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Clinics Table 34. Global Inhalational Anesthesia Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 35. Global Inhalational Anesthesia Drugs Sales Volume by Application (2021-2026) & (k tons) Table 36. Global Inhalational Anesthesia Drugs Sales Volume by Application (2027-2032) & (k tons) Table 37. Global Inhalational Anesthesia Drugs Sales Volume Share by Application (2021-2026) Table 38. Global Inhalational Anesthesia Drugs Sales Volume Share by Application (2027-2032) Table 39. Global Inhalational Anesthesia Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Inhalational Anesthesia Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Inhalational Anesthesia Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Inhalational Anesthesia Drugs Sales Value Share by Application (2021-2026) Table 43. Global Inhalational Anesthesia Drugs Sales Value Share by Application (2027-2032) Table 44. Global Inhalational Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 45. Global Inhalational Anesthesia Drugs Sales by Region (2021-2026) & (k tons) Table 46. Global Inhalational Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 47. Global Inhalational Anesthesia Drugs Sales by Region (2027-2032) & (k tons) Table 48. Global Inhalational Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 49. Global Inhalational Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Inhalational Anesthesia Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Inhalational Anesthesia Drugs Sales Value Share by Region (2021-2026) Table 52. Global Inhalational Anesthesia Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Inhalational Anesthesia Drugs Sales Value Share by Region (2027-2032) Table 54. Global Inhalational Anesthesia Drugs Market Average Price (US$/ton) by Region (2021-2026) Table 55. Global Inhalational Anesthesia Drugs Market Average Price (US$/ton) by Region (2027-2032) Table 56. Global Inhalational Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. Global Inhalational Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Inhalational Anesthesia Drugs Sales by Country (2021-2026) & (k tons) Table 59. Global Inhalational Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 60. Global Inhalational Anesthesia Drugs Sales by Country (2027-2032) & (k tons) Table 61. Global Inhalational Anesthesia Drugs Sales Market Share by Country (2027-2032) Table 62. Global Inhalational Anesthesia Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Inhalational Anesthesia Drugs Sales Value Market Share by Country (2021-2026) Table 64. Global Inhalational Anesthesia Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Inhalational Anesthesia Drugs Sales Value Market Share by Country (2027-2032) Table 66. Halocarbon Products Company Information Table 67. Halocarbon Products Business Overview Table 68. Halocarbon Products Inhalational Anesthesia Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 69. Halocarbon Products Inhalational Anesthesia Drugs Product Portfolio Table 70. Halocarbon Products Recent Development Table 71. Piramal Enterprises Company Information Table 72. Piramal Enterprises Business Overview Table 73. Piramal Enterprises Inhalational Anesthesia Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Piramal Enterprises Inhalational Anesthesia Drugs Product Portfolio Table 75. Piramal Enterprises Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie Inhalational Anesthesia Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. AbbVie Inhalational Anesthesia Drugs Product Portfolio Table 80. AbbVie Recent Development Table 81. Baxter Company Information Table 82. Baxter Business Overview Table 83. Baxter Inhalational Anesthesia Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Baxter Inhalational Anesthesia Drugs Product Portfolio Table 85. Baxter Recent Development Table 86. Fresenius Kabi Company Information Table 87. Fresenius Kabi Business Overview Table 88. Fresenius Kabi Inhalational Anesthesia Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Fresenius Kabi Inhalational Anesthesia Drugs Product Portfolio Table 90. Fresenius Kabi Recent Development Table 91. Jiangsu Hengrui Medicine Company Information Table 92. Jiangsu Hengrui Medicine Business Overview Table 93. Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product Portfolio Table 95. Jiangsu Hengrui Medicine Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Inhalational Anesthesia Drugs Distributors List Table 99. Inhalational Anesthesia Drugs Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Inhalational Anesthesia Drugs Product Image Figure 2. Global Inhalational Anesthesia Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalational Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalational Anesthesia Drugs Sales (2021-2032) & (k tons) Figure 5. Global Inhalational Anesthesia Drugs Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Inhalational Anesthesia Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Isoflurane Image Figure 10. Sevoflurane Image Figure 11. Desflurane Image Figure 12. Enflurane Image Figure 13. Global Inhalational Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Inhalational Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Inhalational Anesthesia Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Inhalational Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Inhalational Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Inhalational Anesthesia Drugs Sales Value Share by Type (2021-2032) Figure 19. Ambulatory Surgical Centers Image Figure 20. Hospitals Image Figure 21. Clinics Image Figure 22. Global Inhalational Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 23. Global Inhalational Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Inhalational Anesthesia Drugs Sales Volume Share by Application (2021-2032) Figure 25. Global Inhalational Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Inhalational Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Inhalational Anesthesia Drugs Sales Value Share by Application (2021-2032) Figure 28. Global Inhalational Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 29. Global Inhalational Anesthesia Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Inhalational Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Inhalational Anesthesia Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Inhalational Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. North America Inhalational Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Inhalational Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Inhalational Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Inhalational Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Inhalational Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Inhalational Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. South America Inhalational Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Inhalational Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Inhalational Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Inhalational Anesthesia Drugs Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Inhalational Anesthesia Drugs Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Desflurane
  • Enflurane
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
Companies covered
  • Halocarbon Products
  • Piramal Enterprises
  • AbbVie
  • Baxter
  • Fresenius Kabi
  • Jiangsu Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalational Anesthesia Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Inhalational Anesthesia Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalational Anesthesia Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalational Anesthesia Drugs Market Dynamics
  1. 2.1 Inhalational Anesthesia Drugs Industry Trends
  2. 2.2 Inhalational Anesthesia Drugs Industry Drivers
  3. 2.3 Inhalational Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Inhalational Anesthesia Drugs Industry Restraints
3 Inhalational Anesthesia Drugs Market by Company
  1. 3.1 Global Inhalational Anesthesia Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Inhalational Anesthesia Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Inhalational Anesthesia Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalational Anesthesia Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Inhalational Anesthesia Drugs Company Ranking (2024-2026)
  6. 3.6 Global Inhalational Anesthesia Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalational Anesthesia Drugs Company Product Type and Application
  8. 3.8 Global Inhalational Anesthesia Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalational Anesthesia Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalational Anesthesia Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalational Anesthesia Drugs Market by Type
  1. 4.1 Inhalational Anesthesia Drugs Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Desflurane
  5. 4.1.4 Enflurane
  6. 4.2 Global Inhalational Anesthesia Drugs Sales Volume by Type
  7. 4.2.1 Global Inhalational Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Inhalational Anesthesia Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Inhalational Anesthesia Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Inhalational Anesthesia Drugs Sales Value by Type
  11. 4.3.1 Global Inhalational Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Inhalational Anesthesia Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Inhalational Anesthesia Drugs Sales Value Share by Type (2021-2032)
5 Inhalational Anesthesia Drugs Market by Application
  1. 5.1 Inhalational Anesthesia Drugs Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.2 Global Inhalational Anesthesia Drugs Sales Volume by Application
  6. 5.2.1 Global Inhalational Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalational Anesthesia Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Inhalational Anesthesia Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Inhalational Anesthesia Drugs Sales Value by Application
  10. 5.3.1 Global Inhalational Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhalational Anesthesia Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Inhalational Anesthesia Drugs Sales Value Share by Application (2021-2032)
6 Inhalational Anesthesia Drugs Regional Sales and Value Analysis
  1. 6.1 Global Inhalational Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalational Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalational Anesthesia Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalational Anesthesia Drugs Sales by Region (2027-2032)
  5. 6.3 Global Inhalational Anesthesia Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalational Anesthesia Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalational Anesthesia Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalational Anesthesia Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalational Anesthesia Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalational Anesthesia Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Inhalational Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalational Anesthesia Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalational Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalational Anesthesia Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalational Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalational Anesthesia Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Inhalational Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalational Anesthesia Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalational Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
7 Inhalational Anesthesia Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Inhalational Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalational Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalational Anesthesia Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalational Anesthesia Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalational Anesthesia Drugs Sales by Country (2027-2032)
  6. 7.4 Global Inhalational Anesthesia Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalational Anesthesia Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalational Anesthesia Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalational Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalational Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalational Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Halocarbon Products
  2. 8.1.1 Halocarbon Products Company Information
  3. 8.1.2 Halocarbon Products Business Overview
  4. 8.1.3 Halocarbon Products Inhalational Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Halocarbon Products Inhalational Anesthesia Drugs Product Portfolio
  6. 8.1.5 Halocarbon Products Recent Developments
  7. 8.2 Piramal Enterprises
  8. 8.2.1 Piramal Enterprises Company Information
  9. 8.2.2 Piramal Enterprises Business Overview
  10. 8.2.3 Piramal Enterprises Inhalational Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Piramal Enterprises Inhalational Anesthesia Drugs Product Portfolio
  12. 8.2.5 Piramal Enterprises Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie Inhalational Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie Inhalational Anesthesia Drugs Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Inhalational Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Inhalational Anesthesia Drugs Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Inhalational Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Inhalational Anesthesia Drugs Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Jiangsu Hengrui Medicine
  32. 8.6.1 Jiangsu Hengrui Medicine Company Information
  33. 8.6.2 Jiangsu Hengrui Medicine Business Overview
  34. 8.6.3 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product Portfolio
  36. 8.6.5 Jiangsu Hengrui Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalational Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 Inhalational Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalational Anesthesia Drugs Sales Mode & Process
  6. 9.2 Inhalational Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalational Anesthesia Drugs Distributors
  9. 9.2.3 Inhalational Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst